TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34551809

Group type: EXPERIMENTAL
Intervention: Healthy Lifestyle Program (HeLP)
Number of subjects: 346

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 346
Study: 34224918

Group type: EXPERIMENTAL
Intervention: Mild intermittent hypoxia (MIH) exposure (15 % O2, 3 × 2 h/day for 7 days)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Mild intermittent hypoxia (MIH) exposure
Number of subjects: 12

Group type: COMPARATOR
Intervention: Normoxia (21 % O2)
Number of subjects: 12
Study: 32172039

Group type: EXPERIMENTAL
Intervention: Perceived 8-h sleep opportunity (actual 5-h sleep)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Perceived 5-h sleep opportunity (actual 8-h sleep)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 5-h sleep opportunity with perceived 5-h sleep
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 5-h sleep opportunity with perceived 8-h sleep
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Perceived 8-h sleep opportunity (regardless of actual duration)
Number of subjects: 16
Study: 36200478

Group type: EXPERIMENTAL
Intervention: Resin infiltration (Icon) with up to 3 etching procedures (Inf)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Fluoride varnish (Tiefenfluorid) (FV)
Number of subjects: 15
Study: 34619106

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg once daily
Number of subjects: 4304

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4304
Study: 33020051

Group type: EXPERIMENTAL
Intervention: Individuals who developed diabetes
Number of subjects: 7163

Group type: EXPERIMENTAL
Intervention: Women who developed diabetes
Number of subjects: 7163

Group type: COMPARATOR
Intervention: Individuals who did not develop diabetes
Number of subjects: 7163
Study: 33452179

Group type: EXPERIMENTAL
Intervention: Pneumatic dilation (PD) using a 35 mm balloon
Number of subjects: 42

Group type: COMPARATOR
Intervention: Sham dilation
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Pneumatic dilation (PD)
Number of subjects: 42
Study: 34994685

Group type: EXPERIMENTAL
Intervention: Verbal feedback
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Written feedback
Number of subjects: 182
Study: 32438879

Group type: EXPERIMENTAL
Intervention: Childhood maltreatment in ultra-high risk individuals
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Physical and emotional neglect
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Physical abuse
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Physical neglect
Number of subjects: 202

Group type: COMPARATOR
Intervention: Control group (no childhood maltreatment)
Number of subjects: 202
Study: 35526590

Group type: EXPERIMENTAL
Intervention: Latanoprostene bunod (LBN) ophthalmic solution 0.024%
Number of subjects: 50

Group type: COMPARATOR
Intervention: Timolol maleate 0.5%
Number of subjects: 50
Study: 34347883

Group type: EXPERIMENTAL
Intervention: Crenezumab (600–7,200 mg)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo (4–40 mL)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Crenezumab with rHuPH20
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Crenezumab (high-dose, high-concentration, high-volume)
Number of subjects: 140
Study: 35978329

Group type: EXPERIMENTAL
Intervention: BI 764524 (0.5, 1.0, or 2.5 mg) in the SRD part
Number of subjects: 30

Group type: COMPARATOR
Intervention: BI 764524 (maximum tolerated dose) in the MD part
Number of subjects: 30
Study: 33451268

Group type: EXPERIMENTAL
Intervention: Office-based pedal desk intervention for 3 months
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group maintaining habitual activity
Number of subjects: 40
Study: 32134208

Group type: EXPERIMENTAL
Intervention: Standard multidomain intervention
Number of subjects: 1082

Group type: EXPERIMENTAL
Intervention: Participant empowerment
Number of subjects: 1082

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1082
Study: 35759826

Group type: EXPERIMENTAL
Intervention: Contralateral isometric handgrip (IHG)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cold pressor test (CPT)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Post-handgrip muscle ischemia (PHGMI)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Mental arithmetic test
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Apnea
Number of subjects: 12
Study: 34386597

Group type: EXPERIMENTAL
Intervention: Terlipressin
Number of subjects: 974

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 974
Study: 34372849

Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 527

Group type: COMPARATOR
Intervention: Control (non-diabetic patients)
Number of subjects: 527
Study: 32014942

Group type: EXPERIMENTAL
Intervention: Whole-brain radiotherapy (WBRT) with 5 fractions of 4 Gy
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Whole-brain radiotherapy (WBRT) with 10 fractions of 3 Gy
Number of subjects: 76

Group type: COMPARATOR
Intervention: Best supportive care
Number of subjects: 76
Study: 35569119

Group type: EXPERIMENTAL
Intervention: Dentist-administered cognitive behavioural therapy (D-CBT)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Four Habits communication model plus midazolam sedation
Number of subjects: 96
Study: 33441760

Group type: EXPERIMENTAL
Intervention: Inland participants (median UIC 188.5 μg/L)
Number of subjects: 2503

Group type: COMPARATOR
Intervention: Coastal participants (median UIC 128.5 μg/L)
Number of subjects: 2503
Study: 35015777

Group type: EXPERIMENTAL
Intervention: Ad26.ZEBOV (5 × 10^10 viral particles) and MVA-BN-Filo (1 × 10^8 infectious units) administered 28 or 56 days apart
Number of subjects: 263

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 263
Study: 33252337

Group type: EXPERIMENTAL
Intervention: CT-guided injection with botulinum toxin
Number of subjects: 97

Group type: COMPARATOR
Intervention: CT-guided injection without botulinum toxin (Control)
Number of subjects: 97
Study: 32028804

Group type: EXPERIMENTAL
Intervention: Perispinal etanercept
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35138714

Group type: EXPERIMENTAL
Intervention: Psilocybin in combination with psychotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Escitalopram in combination with psychotherapy
Number of subjects: 0
Study: 33676015

Group type: EXPERIMENTAL
Intervention: Meniscal pathology present at baseline
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Newly developed meniscal pathology
Number of subjects: 121
Study: 36007434

Group type: EXPERIMENTAL
Intervention: Substance impaired-driving personalized feedback plus MI-style interactive text messaging intervention (PF + MIT)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Substance impaired-driving personalized feedback only intervention (PF)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Substance information control condition (IC)
Number of subjects: 97
Study: 34716085

Group type: EXPERIMENTAL
Intervention: Pegvaliase (Palynziq®)
Number of subjects: 0
Study: 35483093

Group type: EXPERIMENTAL
Intervention: Adaptive COVID-19 Treatment Trial
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Operational lessons learned from the trial
Number of subjects: 0
Study: 32069516

Group type: EXPERIMENTAL
Intervention: Treatment A (fasting condition)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Treatment B (high-calorie, high-fat meal 1 hour postdose)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Treatment C (high-calorie, high-fat meal 2 hours postdose)
Number of subjects: 15
Study: 36228485

Group type: EXPERIMENTAL
Intervention: 40 mg/day pyridoxine
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 33183307

Group type: EXPERIMENTAL
Intervention: Kypho-IORT (combined kyphoplasty and intraoperative radiotherapy)
Number of subjects: 104
Study: 33296464

Group type: EXPERIMENTAL
Intervention: Probiotics (Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2) - total daily dose of 109 CFU for 12 weeks
Number of subjects: 898

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 898
Study: 33028383

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided needling combined with platelet-rich plasma (PRP)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Ultrasound-guided needling combined with saline (control group)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided needling combined with PRP
Number of subjects: 58
Study: 36206592

Group type: EXPERIMENTAL
Intervention: Educational program
Number of subjects: 109

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 109
Study: 33349469

Group type: EXPERIMENTAL
Intervention: Remote exercise instruction (exercises at home, two times a day for four weeks, followed by telephone calls)
Number of subjects: 56

Group type: COMPARATOR
Intervention: In-person exercise instruction (exercises at the clinic, three times a week for four weeks)
Number of subjects: 56
Study: 32606658

Group type: EXPERIMENTAL
Intervention: E‐M14C (Eudragit®-S100 coated PLGA nanoparticles)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Commercial etoricoxib tablets
Number of subjects: 0
Study: 34302312

Group type: EXPERIMENTAL
Intervention: Delirium prevention care protocol (n=41)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Standard nursing care (n=43)
Number of subjects: 84
Study: 33280934

Group type: EXPERIMENTAL
Intervention: Virtual Reality sessions for 15 min twice a week for 6 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: No sessions
Number of subjects: 60
Study: 34196453

Group type: EXPERIMENTAL
Intervention: plasmaMAC
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: UTM
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Plasma UTM
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: MAC
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (untreated surfaces)
Number of subjects: 40
Study: 32505378

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine [1.0 μg.kg‐1 body weight] and morphine [0.48 mg.kg‐1 body weight] (COM Group)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Morphine [0.48 mg.kg‐1] (MOR Group)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine and morphine (COM Group)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Morphine (MOR Group)
Number of subjects: 118
Study: 35385395

Group type: EXPERIMENTAL
Intervention: eHealth intervention with remote support from a lifestyle coach
Number of subjects: 2724

Group type: EXPERIMENTAL
Intervention: High engagement group
Number of subjects: 2724

Group type: EXPERIMENTAL
Intervention: Moderate engagement group
Number of subjects: 2724

Group type: EXPERIMENTAL
Intervention: Low engagement group
Number of subjects: 2724

Group type: EXPERIMENTAL
Intervention: Participants not using a computer regularly
Number of subjects: 2724
Study: 34334624

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 35365139

Group type: EXPERIMENTAL
Intervention: Automated PP-CSF standing orders
Number of subjects: 32

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 32
Study: 33756250

Group type: EXPERIMENTAL
Intervention: BDC supplementation (150 mg/kg)
Number of subjects: 320

Group type: COMPARATOR
Intervention: LPS challenge
Number of subjects: 320
Study: 32620917

Group type: EXPERIMENTAL
Intervention: dMMR CRCs
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: MLH1me+ dMMR CRCs
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: dMMR CRCs bearing receptor tyrosine kinase fusion
Number of subjects: 381
Study: 34308666

Group type: EXPERIMENTAL
Intervention: Self-Generated Identification Codes (SGIC) group
Number of subjects: 1844

Group type: COMPARATOR
Intervention: Anonymous control group
Number of subjects: 1844
Study: 33492349

Group type: EXPERIMENTAL
Intervention: Assistive technology and telecare (ATT)
Number of subjects: 495

Group type: COMPARATOR
Intervention: Limited control of appropriate ATT
Number of subjects: 495
Study: 36114862

Group type: EXPERIMENTAL
Intervention: Adjuvant radiotherapy (RT)
Number of subjects: 4324

Group type: COMPARATOR
Intervention: No adjuvant radiotherapy (RT)
Number of subjects: 4324
Study: 34099018

Group type: EXPERIMENTAL
Intervention: Auricular acupressure for 12 months
Number of subjects: 480

Group type: COMPARATOR
Intervention: Blank control
Number of subjects: 480
Study: 36385793

Group type: EXPERIMENTAL
Intervention: Visual self-assessment card
Number of subjects: 405
Study: 36174744

Group type: EXPERIMENTAL
Intervention: High-dose intravenous hydroxocobalamin (IV-HOC), 5-gram dose
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (0.9% saline solution)
Number of subjects: 20
Study: 32977049

Group type: EXPERIMENTAL
Intervention: Females
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: Males
Number of subjects: 318
Study: 35984578

Group type: EXPERIMENTAL
Intervention: Positive feedback during modified Trier Social Stress Test
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Negative feedback during modified Trier Social Stress Test
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cardiac vagal control (CVC) measures
Number of subjects: 60
Study: 33781596

Group type: EXPERIMENTAL
Intervention: ONCAB group (1056 patients)
Number of subjects: 2103

Group type: COMPARATOR
Intervention: OPCAB group (1047 patients)
Number of subjects: 2103
Study: 32699107

Group type: EXPERIMENTAL
Intervention: Women in rural areas
Number of subjects: 805

Group type: COMPARATOR
Intervention: Men in rural areas
Number of subjects: 805

Group type: COMPARATOR
Intervention: Women in urban areas
Number of subjects: 805

Group type: EXPERIMENTAL
Intervention: Men in urban areas
Number of subjects: 805

Group type: COMPARATOR
Intervention: Rural women vs rural men
Number of subjects: 805

Group type: COMPARATOR
Intervention: Urban women vs urban men
Number of subjects: 805

Group type: EXPERIMENTAL
Intervention: Overall diabetes prevalence
Number of subjects: 805
Study: 33154039

Group type: EXPERIMENTAL
Intervention: REACH (tailored text messaging intervention)
Number of subjects: 506

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 506
Study: 32563787

Group type: EXPERIMENTAL
Intervention: Mupirocin
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Povidone-iodine
Number of subjects: 62

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 62
Study: 37904182

Group type: EXPERIMENTAL
Intervention: Mindfulness-based mobile apps
Number of subjects: 60
Study: 33676474

Group type: EXPERIMENTAL
Intervention: Members of the sports organization
Number of subjects: 3015

Group type: COMPARATOR
Intervention: Controls (matched general population)
Number of subjects: 3015
Study: 32930649

Group type: EXPERIMENTAL
Intervention: Digital breast tomosynthesis combined with two-dimensional synthetic mammography (DBT+SM)
Number of subjects: 28749

Group type: COMPARATOR
Intervention: Digital mammography (DM)
Number of subjects: 28749
Study: 35021263

Group type: EXPERIMENTAL
Intervention: Earplugs and eye masks during the night (experimental group)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Comparison of experimental and control groups on RCSQ and ICDSC scores
Number of subjects: 84
Study: 35614848

Group type: COMPARATOR
Intervention: BMI
Number of subjects: 547
Study: 33538306

Group type: EXPERIMENTAL
Intervention: Healthy Me, Healthy We (HMHW) social marketing campaign
Number of subjects: 48
Study: 35175317

Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan (194/206 mg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sitagliptin
Number of subjects: 19
Study: 33069714

Group type: EXPERIMENTAL
Intervention: Filtered air + allergen
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Diesel exhaust (DE) + allergen
Number of subjects: 11

Group type: COMPARATOR
Intervention: Filtered air + saline
Number of subjects: 11
Study: 32657457

Group type: EXPERIMENTAL
Intervention: Glycopyrrolate up to 4.5 mg/d
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 35726548

Group type: EXPERIMENTAL
Intervention: Zinc oxide‐eugenol
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Mineral trioxide aggregate
Number of subjects: 105
Study: 34098951

Group type: EXPERIMENTAL
Intervention: TdaP5-IPV (n = 67)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: TdaP3-IPV (n = 63)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Unvaccinated mothers (n = 45)
Number of subjects: 154
Study: 32653022

Group type: EXPERIMENTAL
Intervention: Unilateral pulsed jet lavage (irrigated group)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standardized vertebroplasty without irrigation (control group)
Number of subjects: 30
Study: 35708706

Group type: EXPERIMENTAL
Intervention: Port Delivery System (PDS) with ranibizumab, 100 mg/mL, fixed refill exchanges every 24 weeks
Number of subjects: 415

Group type: COMPARATOR
Intervention: Intravitreal ranibizumab injections, 0.5 mg, every 4 weeks
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Port Delivery System (PDS)
Number of subjects: 415

Group type: COMPARATOR
Intervention: Concurrent fellow-eye injections
Number of subjects: 415
Study: 33904284

Group type: EXPERIMENTAL
Intervention: Simodont virtual simulation system
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional phantom‐simulator system
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Simodont virtual simulation system followed by conventional phantom‐simulator system
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional phantom‐simulator system followed by Simodont virtual simulation system
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Conventional phantom‐simulator system after using Simodont virtual simulation system
Number of subjects: 20
Study: 32228238

Group type: EXPERIMENTAL
Intervention: Text messaging intervention for hypertension management
Number of subjects: 333
Study: 35734974

Group type: EXPERIMENTAL
Intervention: Hydrogen/oxygen inhalation for 13 weeks
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Hydrogen/oxygen inhalation
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Hydrogen incubation (20%)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Hydrogen treatment
Number of subjects: 43
Study: 34081385

Group type: EXPERIMENTAL
Intervention: 75 g glucose to induce PBH
Number of subjects: 10

Group type: COMPARATOR
Intervention: Aspartame to leave glycaemia unchanged
Number of subjects: 10
Study: 35437929

Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan (200 mg/day)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Valsartan (160 mg/day)
Number of subjects: 64
Study: 32656739

Group type: EXPERIMENTAL
Intervention: Oncokompas eHealth application
Number of subjects: 625

Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 625
Study: 35196474

Group type: EXPERIMENTAL
Intervention: Computerized social cognition (SC) module + non-SC module (experimental group, n=28)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Non-SC module only (control group, n=26)
Number of subjects: 45
Study: 34312964

Group type: EXPERIMENTAL
Intervention: Single assistant robotic surgery (SA-RS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dual assistant robotic surgery (D-RS)
Number of subjects: 0
Study: 32910197

Group type: EXPERIMENTAL
Intervention: Collagen/cell group (hUC-MSC-laden collagen hydrogel intramyocardial injection)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cell group (hUC-MSCs alone)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (CABG alone)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 50
Study: 35430680

Group type: EXPERIMENTAL
Intervention: Predictive model for acute kidney injury (AKI) using clinical features and machine learning.
Number of subjects: 996

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting AKI and severe AKI.
Number of subjects: 996
Study: 33347912

Group type: EXPERIMENTAL
Intervention: Competition task (rock-paper-scissors game)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control task (assessing facial expressions)
Number of subjects: 0
Study: 32465460

Group type: EXPERIMENTAL
Intervention: Exercise-based inpatient cardiac rehabilitation (CR)
Number of subjects: 435

Group type: EXPERIMENTAL
Intervention: Patients with ICM
Number of subjects: 435

Group type: EXPERIMENTAL
Intervention: Patients after myocarditis
Number of subjects: 435

Group type: EXPERIMENTAL
Intervention: Patients with atrial fibrillation
Number of subjects: 435

Group type: EXPERIMENTAL
Intervention: Patients with at least intermittent opening of aortic valve
Number of subjects: 435
Study: 33527576

Group type: EXPERIMENTAL
Intervention: L-menthol (160 mg)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: L-menthol (160 mg) and Placebo
Number of subjects: 220
Study: 32458567

Group type: EXPERIMENTAL
Intervention: Treat All
Number of subjects: 3405

Group type: COMPARATOR
Intervention: Standard of Care (SoC)
Number of subjects: 3405
Study: 35561721

Group type: EXPERIMENTAL
Intervention: Intrathecal human antitoxin
Number of subjects: 272

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Human intramuscular antitoxin
Number of subjects: 272

Group type: COMPARATOR
Intervention: Equine intramuscular antitoxin
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Intrathecal group
Number of subjects: 272
Study: 32688143

Group type: EXPERIMENTAL
Intervention: Multidisciplinary rehabilitation intervention (aerobic and resistance exercise, cognitive training, dual-task training, sleep hygiene and nutritional guidance)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Multidisciplinary rehabilitation intervention
Number of subjects: 31

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 31
Study: 36041469

Group type: EXPERIMENTAL
Intervention: Flipped Classroom (FC)
Number of subjects: 244

Group type: COMPARATOR
Intervention: Traditional Didactics (TD)
Number of subjects: 244